Richard Pazdur, head of FDA’s Oncology Center of Excellence [via FDA]
AstraZeneca, Merck win quick OK for a rare disease drug — as the FDA declares it can still move fast during a crippling pandemic
The pandemic may have altered the course of life as we know it, for awhile, but the FDA wants you to know that it is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
